Skip to content

Study on the effect of Esophageal Temperature on the incidence of Esophageal Lesions after Atrial Fibrillation Ablation

A prospective randomized study on the effect of oesophageal temperature monitoring on the incidence of esophageal lesions after left atrial ablation for the treatment of atrial fibrillation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2yvgyf
Enrollment
Unknown
Registered
2018-09-05
Start date
2017-07-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation, esophageal ulcer, esophageal fistula, flutter and atrial fibrillation

Interventions

Patients will be allocated in 3 groups with different strategies of esophageal protection for radiofrequency application in the posterior wall of the left atrium, by randomization in a ratio of 1: 1:
Device

Sponsors

Hospital das Clínicas da Faculdade de Medicina da USP
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina da USP
Collaborator

Eligibility

Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with paroxysmal or persistent AF, diagnosed by electrocardiogram, 24-hour Holter, or monitors of implantable or non-implantable events, with at least one episode of AF up to 12 months before the procedure. Patients should be willing and able to sign an informed consent form, and to undergo all procedures described in both the study protocol and the consent form.

Exclusion criteria

Exclusion criteria: Atrial thrombus in the left atrium; history of AF ablation; history of cardiac surgery; contraindication to anticoagulation; permanent AF; New York Heart Association functional class III or IV; stroke in the last 3 months; pregnancy, history blood clotting abnormalities; previous esophageal surgery; or advanced chronic kidney disease (creatinine > 2.5 mg/dl).

Design outcomes

Primary

MeasureTime frame
Incidence of esophageal lesions evaluated by upper digestive endoscopy within three days after the ablation procedure.

Secondary

MeasureTime frame
Rate of recurrence of AF at six months after ablation assessed by ECG, Holter 24 hours or clinically.;Isolation rate of pulmonary veins at the end of ablation.;Duration of the AF ablation procedure.Incidence of atrio-esophageal fistulas at six months.;Difference in the size of the esophageal lesions evaluated in the upper digestive endoscopy.;Persistence of esophageal lesions in the second upper endoscopy.;Maximum esophageal temperature reached during ablation.

Countries

Brazil

Contacts

Public ContactDaniel Moura

Hospital das Clínicas da Faculdade de Medicina da USP

danielmcm@gmail.com+5583998003448

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 4, 2026